Valuation: COMPASS Pathways plc

Market Cap 1.88B 1.65B 1.53B 1.41B 2.67B 180B 2.73B 18.35B 7.13B 88.31B 7.08B 6.92B 307B P/E 2026 *
-14.7x
P/E 2027 * -9.84x
Enterprise Value 1.46B 1.28B 1.18B 1.09B 2.07B 140B 2.11B 14.22B 5.52B 68.43B 5.48B 5.36B 238B EV / Sales 2026 *
-
EV / Sales 2027 * 22.6x
Free-Float
25.07%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: COMPASS Pathways plc

1 day+7.51%
1 week+5.08%
Current month-1.31%
1 month+19.05%
3 months+144.14%
6 months+83.27%
Current year+102.39%
1 week 11.56
Extreme 11.56
14.15
1 month 10.72
Extreme 10.724
15.4
Current year 4.88
Extreme 4.88
15.4
1 year 3.45
Extreme 3.45
15.4
3 years 2.25
Extreme 2.25
15.4
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 01/08/2022
Director of Finance/CFO 54 01/03/2024
Chief Tech/Sci/R&D Officer 66 01/05/2024
Director TitleAgeSince
Director/Board Member 73 29/10/2025
Chairman 69 03/09/2024
Chairman 74 29/03/2024
Date Insider Type Main position Quantity % Market Cap.
05-27Free

Chairman

30,158 0.0314%
05-27Free

Director

21,110 0.0220%
05-27Free

Director

21,110 0.0220%
Change 5-day change 1-year change 3-year change Capi.($)
+7.51%+5.08%+303.61%+41.35% 1.88B
+0.31%+1.66%+2.03%+8.59% 49.42B
-0.36%+1.21%+420.77%+619.10% 40.34B
-2.13%+0.29%+23.91%-6.01% 34.01B
-2.29%+3.83%+23.48%+59.26% 33.56B
-0.79%+1.32%+5.78%+36.42% 26.84B
+3.82%+3.51% - - 17.22B
-2.62%-2.13%+64.96%+125.87% 15.19B
-2.17%+6.65%+104.31%+102.15% 13.96B
-0.45%-3.36%+11.93%+17.35% 13.36B
Average +0.09%+0.51%+106.75%+111.56% 24.58B
Weighted average by Cap. -0.67%+1.46%+96.28%+139.17%

Financials

2026 *2027 *
Net sales - 61.21M 53.68M 49.56M 45.8M 86.81M 5.86B 88.55M 596M 232M 2.87B 230M 225M 9.96B
Net income -100M -88M -81.25M -75.08M -142M -9.61B -145M -977M -380M -4.7B -377M -369M -16.32B -197M -173M -159M -147M -279M -18.86B -285M -1.92B -745M -9.23B -740M -723M -32.03B
Net Debt -424M -372M -343M -317M -602M -40.61B -614M -4.13B -1.6B -19.87B -1.59B -1.56B -68.99B -504M -442M -408M -377M -715M -48.29B -730M -4.91B -1.91B -23.63B -1.89B -1.85B -82.03B
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
08/07/26 $13.97 +7.51% 7,532,720
07/07/26 $12.99 +1.17% 14,233,189
06/07/26 $12.84 -5.73% 3,202,169
02/07/26 $13.62 +2.48% 4,103,686
01/07/26 $13.29 -6.08% 4,743,546
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
13.96USD
Average target price
24.47USD
Spread / Average Target
+75.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock